According to Galectin Therapeutics's latest financial reports the company's total assets are $28.2 M. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2022-12-31 | $21.28 M | -49.11% |
2021-12-31 | $41.82 M | 41.31% |
2020-12-31 | $29.6 M | -38.93% |
2019-12-31 | $48.46 M | 438.16% |
2018-12-31 | $9 M | 116.44% |
2017-12-31 | $4.16 M | -73.66% |
2016-12-31 | $15.79 M | -40.19% |
2015-12-31 | $26.4 M | -11.02% |
2014-12-31 | $29.67 M | 177.02% |
2013-12-31 | $10.71 M | 12.05% |
2012-12-31 | $9.56 M | 44.6% |
2011-12-31 | $6.61 M | 4.95% |
2010-12-31 | $6.3 M | 1344.95% |
2009-12-31 | $0.43 M | -38.07% |
2008-12-31 | $0.7 M | -60.49% |
2007-12-31 | $1.78 M | -71.99% |
2006-12-31 | $6.36 M | 28.21% |
2005-12-31 | $4.96 M | -55.33% |
2004-12-31 | $11.11 M | 38.84% |
2003-12-31 | $8 M | 250.48% |
2002-12-31 | $2.28 M | 29.24% |
2001-12-31 | $1.76 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Mirati Therapeutics MRTX | $1.12 B | 3,906.06% | ๐บ๐ธ USA |
MannKind Corp MNKD | $0.47 B | 1,585.10% | ๐บ๐ธ USA |